Streatham & Clapham Health Renal Outreach Clinic

Slides:



Advertisements
Similar presentations
Detection, monitoring and referral of chronic kidney disease
Advertisements

Chronic kidney disease
Chronic kidney disease
Hisham Abdelwahab MRCP U.K MMed/SCI
Proteinuria and Haematuria – an update Alex Heaton
CKD ML/LH What are people hoping to cover from the session today?
Practicalities of Palliative Care
Multicenter database of clinical course of CKD patients Internal Medicine Jang Hye Ryoun.
Making a difference to Staying Healthy Jeff Seneviratne Joint Clinical Lead Chair, Biochemistry NAG GM Pathology Network.
Management of Stage 3 Chronic Kidney Disease (CKD) in General Practice
Dr David MAKANJUOLA Renal unit St. Helier hospital
Algorithm Dr. Patrice Junod Clinique médicale l’Actuel This activity is supported by an educational grant from:
Case Study This activity is supported by an educational grant from: Aging Woman with longstanding HIV and multiple comorbidities Dr. Gord Arbess.
SOCIETY OF RENAL NUTRITION AND METABOLISM (SRNM)
WHAT’S NEW IN CHRONIC KIDNEY DISEASE Thomas G. Ferguson, MD State Lead, CKD 4/30/13.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Nephrotic Syndrome in Children Laura Cornish GPST2 Airedale VTS
Diabetic Nephropathy.  Over 40% of new cases of end-stage renal disease (ESRD) are attributed to diabetes.  In 2001, 41,312 people with diabetes began.
Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Renal replacement therapy - indications. S. Zmonarski.
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
European Forum for Primary Care TURKEY DR: OLIMPIA-MARIA VARVA, MEDICAL SCIENTIST (MS) FAMILY PHYSICIAN, EFPC, EGPRN Medicine Dr.Varva - Family Medicine.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Dietary Phosphorus Restriction for Control of PTH in CKD Guideline 4.1. Restriction of Dietary Phosphorus in Patients with CKD  Dietary phosphorus should.
Making life easier… Dr Michael Gordon GP Gleadless Medical Centre Sheffield
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
18 week commissioning pathways for kidney disease and renal transplantation Specialty Clinical Leads Lawrence Goldberg: CKD and ESRF pathways John Scoble:
RENAL BLOOD TESTS WHAT DO THEY MEAN, WHERE TO GO FOR WHAT TO DO.
Ken Chow. What is haematuria?  Macroscopic Visible haematuria Pink or red  Microscopic Gold standard – Microscopy ○ Presence of >3 RBCs per high-powered.
Chronic Kidney Disease NICE Guidelines 2008 Dr Jennifer Kuo Dr Naeema Rashid Dr Shamita Das.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Case Presentation Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital.
Chronic Kidney Disease
Continuity Clinic Proteinuria. Continuity Clinic.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
RENAL DISEASE IN DIABETES
Clinical Biochemistry FAQ for GP Trainees Dr Mourad Labib Consultant Chemical Pathologist DGOH NHS Foundation Trust July 2009.
An update on chronic renal failure: follow-up and when to refer ? Assoc Prof Johan Rosman Renal Department Waitemata DHB
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
Section 5: Configuration of healthcare to manage CKD.
Chronic Kidney Disease (CKD) Epidemiology A NEW EPIDEMIC: CHRONIC KIDNEY DISEASE IN GENERAL POPULATION REAL PREVALENCE AND RELATED FACTORS Josep M. Galceran,
Expert Systems in Renal Disease Kent Renal ServiceUniversity of KentSalford Hospital Chris Farmer Bernhard Klebe Jean IrvingDonal O’Donoghue Paul StevensRoger.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
“Do Once and Share” Feedback from the Renal Team B Stribling, K Harris, A Keogh, J Medcalf.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Predicting Progression in Diabetic Nephropathy: New Biomarker: sTNFR1* Circulating soluble Tumor Necrosis Factor Receptor 1.
1 Project supported by A Package of Innovation for Managing kidney disease in primary care Registered Office: Nene Hall, Lynch Wood Park, Peterborough.
NICE Chronic Kidney Disease (CKD) Guidance 2014 Chronic kidney disease in adults: assessment and management (CG182)
Case 2 A 23-year old Indian young man Homozygous Beta-Thalassemia Major Diagnosed at the age of 6 months. On regular transfusion every 4 weeks since that.
Local Enhanced Service Care bundles Dr Andy Kilpatrick, Clinical Lead.
CKD Update Naveed Ghaffar CKD Lead NMCCG. Outline Introduction- CCG Work Physiology: The Kidney in health CKD : The kidney in disease NICE Update: July.
Section 4: Managing progression of CKD
Section 6: Management in primary care
Diabetes Clinical Audit- July/Aug 2014
Darshika Chhabra, MD, MPH
NDA – THE LATEST DATA Prof Roger Gadsby MBE FRCGP Honorary Associate Clinical Professor , WMS GP Clinical Lead National Diabetes Audit.
Multimorbidity and diabetes - what to do?
Community Kidney e-clinic referral
Section 5: Configuration of healthcare to manage CKD
Chronic Kidney Disease
CHRODIS PLUS Croatian pilot – Baseline analysis of indicators
Multimorbidity and diabetes - what to do?
Presentation transcript:

Streatham & Clapham Health Renal Outreach Clinic Dr Debasish Banerjee, Consultant Nephrologist, St. George’s Hospital Dr Azhar Ala, General Practitioner,Wandsworth Road Honorary Clinician, Dept. Renal Medicine, St. George’s Hospital

Who to refer STAGE 3 CKD (eGFR 30-59) STAGE 4 CKD (eGFR 15-29) Progressive fall in GFR (>4ml/min per year) Microscopic haematuria Proteinuria, if prot/creat ratio >100mg/mmol Unexplained anaemia (Hb <110g/l), abnormal potassium, calcium or phosphate Suspected systemic illness (e.g. SLE) Uncontrolled BP (>150/90 on 3 agents) STAGE 4 CKD (eGFR 15-29) Not achieving target BP control ie <130/80 or <125/75 for prot/creat ratio >100mg/mmol

HOW TO REFER Performa Fax through to secretary AT ST.GEORGE’S Contact back if need more information Able to give clinic letter to patient at end of appointment AND FAX TO GP

Valuable information for referral Brief history - particularly noting urinary symptoms, previous blood pressures, urine testing. Medications Urine dipstick - and protein/creatinine ratio if +. Blood tests - FBC, urea and electrolytes, calcium, albumin, phosphate, cholesterol, HbA1c if diabetic. Previous tests of renal function with dates, back to normal renal function if possible Imaging - results of renal imaging if undertaken

REQUIREMENT FOR FOLLOWUP Blood tests Repeat urine quantification if needed Ultrasound if needed

Start JAN 2008 GRACEFIELD GARDENS Evaluation Survey of patients and practices Patient satisfaction- DOCTOR,INFORMATION Referring physician satisfaction Rate of GFR decline BP control- Initial visit and follow up Conversion of referrals to secondary care Start JAN 2008 GRACEFIELD GARDENS 3 MONTH PILOT INITIALLY